CN Stock MarketDetailed Quotes

000756 Shandong Xinhua Pharmaceutical

Watchlist
  • 16.39
  • +0.54+3.41%
Market Closed Dec 20 15:00 CST
11.18BMarket Cap24.95P/E (TTM)

Shandong Xinhua Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
3.64%6.73B
1.29%4.73B
-6.25%2.47B
7.97%8.1B
19.15%6.5B
27.51%4.67B
44.15%2.64B
14.37%7.5B
10.39%5.45B
3.19%3.66B
Operating revenue
3.64%6.73B
1.29%4.73B
-6.25%2.47B
7.97%8.1B
19.15%6.5B
27.51%4.67B
44.15%2.64B
14.37%7.5B
10.39%5.45B
3.19%3.66B
Other operating revenue
----
-1.58%75.88M
----
-30.33%144.78M
----
-36.97%77.11M
----
3.63%207.82M
----
133.33%122.33M
Total operating cost
4.93%6.34B
2.38%4.41B
-5.33%2.33B
7.27%7.53B
18.00%6.04B
25.93%4.31B
44.40%2.46B
13.72%7.02B
11.39%5.12B
4.81%3.42B
Operating cost
11.82%5.15B
8.13%3.55B
-0.86%1.8B
4.45%5.71B
14.21%4.61B
21.00%3.28B
36.14%1.81B
14.19%5.47B
13.49%4.03B
7.98%2.71B
Operating tax surcharges
-34.27%51.66M
-38.98%36.9M
-56.17%18.43M
41.14%92.18M
61.26%78.6M
91.30%60.48M
156.99%42.06M
10.20%65.31M
9.44%48.74M
0.07%31.61M
Operating expense
-21.64%504.22M
-17.14%403.57M
-17.52%291.06M
18.51%780.17M
42.03%643.45M
65.35%487.04M
114.72%352.9M
12.70%658.31M
-0.28%453.05M
-17.81%294.56M
Administration expense
-18.59%292.41M
-26.49%181.07M
-37.52%78.84M
13.30%513.82M
16.68%359.16M
21.27%246.32M
24.33%126.17M
29.70%453.53M
20.73%307.8M
20.16%203.11M
Financial expense
9.12%10.21M
20.56%1.62M
-81.02%2.95M
-48.93%16.35M
-40.86%9.36M
-90.75%1.34M
26.88%15.57M
-39.47%32.02M
-59.36%15.83M
-45.41%14.5M
-Interest expense (Financial expense)
-11.33%28.12M
-16.85%17.87M
-21.92%9.22M
-17.22%41.15M
-14.42%31.71M
-11.85%21.49M
-5.82%11.8M
-6.40%49.71M
-8.49%37.05M
-10.12%24.38M
-Interest Income (Financial expense)
14.27%-8.32M
31.95%-4.58M
22.18%-2.88M
-17.57%-12.3M
-50.52%-9.71M
-84.60%-6.73M
-161.86%-3.7M
-19.21%-10.46M
-5.46%-6.45M
12.08%-3.65M
Research and development
-4.28%326.67M
3.22%243.11M
26.57%141.91M
21.29%419.24M
32.03%341.28M
39.72%235.53M
42.36%112.12M
1.26%345.66M
4.49%258.5M
-0.99%168.57M
Credit Impairment Loss
-161.42%-8.07M
-135.60%-8.19M
13,900.00%70K
-102.82%-10.29M
-51.93%-3.09M
-71.09%-3.48M
--500
-289.12%-5.08M
57.27%-2.03M
57.27%-2.03M
Asset Impairment Loss
-8.96%-48.31M
-8.96%-48.31M
----
-59.17%-69.28M
-51.08%-44.34M
-51.08%-44.34M
----
-30.84%-43.53M
15.21%-29.35M
16.02%-29.35M
Other net revenue
110.46%1.19M
59.65%-10.72M
295.08%24.79M
-509.37%-35.36M
-510.35%-11.41M
-903.12%-26.56M
1.35%6.27M
-114.78%-5.8M
330.56%2.78M
87.36%-2.65M
Invest income
-13.31%8.4M
14.85%9.52M
1,423.42%1.19M
14.57%9.58M
-5.91%9.69M
-21.29%8.29M
-46.90%78.03K
4.34%8.36M
75.49%10.3M
48.34%10.53M
-Including: Investment income associates
-85.73%217.37K
1,006.56%1.33M
1,423.42%1.19M
217.01%1.42M
-35.98%1.52M
-95.38%120.59K
-46.90%78.03K
141.08%447.18K
173.49%2.38M
337.48%2.61M
Asset deal income
-85.49%1.2M
-2.66%1.24M
60.97%845.11K
57.66%8.73M
308.47%8.28M
-48.08%1.27M
14.64%525.02K
167.25%5.54M
241.48%2.03M
3,521.59%2.45M
Other revenue
165.77%47.98M
199.54%35.03M
300.03%22.68M
-10.36%25.9M
-17.33%18.05M
-25.76%11.7M
1.52%5.67M
-51.63%28.89M
-31.12%21.84M
35.94%15.75M
Operating profit
-10.88%398.27M
-7.90%307.57M
-8.20%170.56M
12.14%534.58M
32.18%446.87M
40.46%333.96M
38.96%185.8M
12.01%476.71M
-1.78%338.08M
-9.66%237.76M
Add:Non operating Income
-84.28%659.43K
-48.33%326.56K
-46.13%193.82K
195.38%5.54M
215.97%4.19M
-8.06%632.02K
71.64%359.78K
-50.96%1.87M
24.63%1.33M
-10.00%687.43K
Less:Non operating expense
31.07%6.01M
71.53%4.53M
59.81%1.98M
9.21%7.43M
-4.44%4.59M
-15.72%2.64M
-37.33%1.24M
-16.79%6.81M
-8.75%4.8M
-12.76%3.14M
Total profit
-12.00%392.92M
-8.61%303.36M
-8.73%168.77M
12.91%532.69M
33.43%446.48M
41.06%331.95M
40.15%184.92M
12.00%471.77M
-1.59%334.61M
-9.62%235.32M
Less:Income tax cost
-18.88%37.47M
-45.62%30.6M
-23.95%23.51M
-41.80%26.58M
47.04%46.19M
52.84%56.27M
37.22%30.91M
-22.81%45.66M
-26.54%31.41M
-27.88%36.81M
Net profit
-11.20%355.45M
-1.06%272.77M
-5.68%145.26M
18.77%506.11M
32.02%400.29M
38.88%275.68M
40.75%154.01M
17.69%426.11M
2.00%303.2M
-5.17%198.5M
Net profit from continuing operation
-11.20%355.45M
-1.06%272.77M
-5.68%145.26M
18.77%506.11M
32.02%400.29M
38.88%275.68M
40.75%154.01M
17.69%426.11M
2.00%303.2M
-5.17%198.5M
Less:Minority Profit
36.63%11.37M
25.35%7.36M
40.64%3.38M
-36.23%9.59M
-14.68%8.32M
42.75%5.87M
163.02%2.41M
11.24%15.05M
-18.15%9.75M
-55.45%4.11M
Net profit of parent company owners
-12.22%344.08M
-1.63%265.4M
-6.41%141.88M
20.79%496.51M
33.58%391.97M
38.80%269.81M
39.72%151.6M
17.94%411.06M
2.84%293.44M
-2.85%194.39M
Earning per share
Basic earning per share
-13.79%0.5
-2.50%0.39
-8.70%0.21
19.35%0.74
28.89%0.58
33.33%0.4
35.29%0.23
10.71%0.62
-2.17%0.45
-6.25%0.3
Diluted earning per share
-12.28%0.5
-2.56%0.38
-4.55%0.21
18.03%0.72
29.55%0.57
30.00%0.39
29.41%0.22
8.93%0.61
-2.22%0.44
-6.25%0.3
Other composite income
208.26%74.96M
96.98%27.33M
-89.42%815.33K
113.41%1.74M
209.72%24.32M
243.00%13.87M
152.81%7.71M
73.13%-12.94M
53.84%-22.16M
74.22%-9.7M
Other composite income of parent company owners
215.13%75.22M
106.79%27.6M
-89.77%807.37K
110.56%1.49M
201.01%23.87M
228.81%13.35M
154.25%7.89M
70.52%-14.13M
50.72%-23.63M
72.38%-10.36M
Other composite income of minority owners
-158.71%-262.39K
-152.07%-273.92K
104.40%7.95K
-79.36%244.75K
-69.55%446.91K
-20.32%526.05K
-240.36%-180.97K
577.34%1.19M
2,326.25%1.47M
709.34%660.24K
Total composite income
1.37%430.41M
3.64%300.09M
-9.67%146.08M
22.91%507.84M
51.09%424.61M
53.36%289.55M
70.55%161.72M
31.62%413.17M
12.76%281.03M
9.97%188.8M
Total composite income of parent company owners
0.83%419.3M
3.48%293.01M
-10.54%142.69M
25.46%498M
54.12%415.84M
53.86%283.15M
69.75%159.49M
32.03%396.94M
13.66%269.81M
13.20%184.03M
Total composite income of minority owners
26.67%11.11M
10.76%7.09M
52.43%3.39M
-39.38%9.84M
-21.85%8.77M
34.03%6.4M
158.25%2.23M
22.26%16.23M
-5.31%11.22M
-47.68%4.77M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 3.64%6.73B1.29%4.73B-6.25%2.47B7.97%8.1B19.15%6.5B27.51%4.67B44.15%2.64B14.37%7.5B10.39%5.45B3.19%3.66B
Operating revenue 3.64%6.73B1.29%4.73B-6.25%2.47B7.97%8.1B19.15%6.5B27.51%4.67B44.15%2.64B14.37%7.5B10.39%5.45B3.19%3.66B
Other operating revenue -----1.58%75.88M-----30.33%144.78M-----36.97%77.11M----3.63%207.82M----133.33%122.33M
Total operating cost 4.93%6.34B2.38%4.41B-5.33%2.33B7.27%7.53B18.00%6.04B25.93%4.31B44.40%2.46B13.72%7.02B11.39%5.12B4.81%3.42B
Operating cost 11.82%5.15B8.13%3.55B-0.86%1.8B4.45%5.71B14.21%4.61B21.00%3.28B36.14%1.81B14.19%5.47B13.49%4.03B7.98%2.71B
Operating tax surcharges -34.27%51.66M-38.98%36.9M-56.17%18.43M41.14%92.18M61.26%78.6M91.30%60.48M156.99%42.06M10.20%65.31M9.44%48.74M0.07%31.61M
Operating expense -21.64%504.22M-17.14%403.57M-17.52%291.06M18.51%780.17M42.03%643.45M65.35%487.04M114.72%352.9M12.70%658.31M-0.28%453.05M-17.81%294.56M
Administration expense -18.59%292.41M-26.49%181.07M-37.52%78.84M13.30%513.82M16.68%359.16M21.27%246.32M24.33%126.17M29.70%453.53M20.73%307.8M20.16%203.11M
Financial expense 9.12%10.21M20.56%1.62M-81.02%2.95M-48.93%16.35M-40.86%9.36M-90.75%1.34M26.88%15.57M-39.47%32.02M-59.36%15.83M-45.41%14.5M
-Interest expense (Financial expense) -11.33%28.12M-16.85%17.87M-21.92%9.22M-17.22%41.15M-14.42%31.71M-11.85%21.49M-5.82%11.8M-6.40%49.71M-8.49%37.05M-10.12%24.38M
-Interest Income (Financial expense) 14.27%-8.32M31.95%-4.58M22.18%-2.88M-17.57%-12.3M-50.52%-9.71M-84.60%-6.73M-161.86%-3.7M-19.21%-10.46M-5.46%-6.45M12.08%-3.65M
Research and development -4.28%326.67M3.22%243.11M26.57%141.91M21.29%419.24M32.03%341.28M39.72%235.53M42.36%112.12M1.26%345.66M4.49%258.5M-0.99%168.57M
Credit Impairment Loss -161.42%-8.07M-135.60%-8.19M13,900.00%70K-102.82%-10.29M-51.93%-3.09M-71.09%-3.48M--500-289.12%-5.08M57.27%-2.03M57.27%-2.03M
Asset Impairment Loss -8.96%-48.31M-8.96%-48.31M-----59.17%-69.28M-51.08%-44.34M-51.08%-44.34M-----30.84%-43.53M15.21%-29.35M16.02%-29.35M
Other net revenue 110.46%1.19M59.65%-10.72M295.08%24.79M-509.37%-35.36M-510.35%-11.41M-903.12%-26.56M1.35%6.27M-114.78%-5.8M330.56%2.78M87.36%-2.65M
Invest income -13.31%8.4M14.85%9.52M1,423.42%1.19M14.57%9.58M-5.91%9.69M-21.29%8.29M-46.90%78.03K4.34%8.36M75.49%10.3M48.34%10.53M
-Including: Investment income associates -85.73%217.37K1,006.56%1.33M1,423.42%1.19M217.01%1.42M-35.98%1.52M-95.38%120.59K-46.90%78.03K141.08%447.18K173.49%2.38M337.48%2.61M
Asset deal income -85.49%1.2M-2.66%1.24M60.97%845.11K57.66%8.73M308.47%8.28M-48.08%1.27M14.64%525.02K167.25%5.54M241.48%2.03M3,521.59%2.45M
Other revenue 165.77%47.98M199.54%35.03M300.03%22.68M-10.36%25.9M-17.33%18.05M-25.76%11.7M1.52%5.67M-51.63%28.89M-31.12%21.84M35.94%15.75M
Operating profit -10.88%398.27M-7.90%307.57M-8.20%170.56M12.14%534.58M32.18%446.87M40.46%333.96M38.96%185.8M12.01%476.71M-1.78%338.08M-9.66%237.76M
Add:Non operating Income -84.28%659.43K-48.33%326.56K-46.13%193.82K195.38%5.54M215.97%4.19M-8.06%632.02K71.64%359.78K-50.96%1.87M24.63%1.33M-10.00%687.43K
Less:Non operating expense 31.07%6.01M71.53%4.53M59.81%1.98M9.21%7.43M-4.44%4.59M-15.72%2.64M-37.33%1.24M-16.79%6.81M-8.75%4.8M-12.76%3.14M
Total profit -12.00%392.92M-8.61%303.36M-8.73%168.77M12.91%532.69M33.43%446.48M41.06%331.95M40.15%184.92M12.00%471.77M-1.59%334.61M-9.62%235.32M
Less:Income tax cost -18.88%37.47M-45.62%30.6M-23.95%23.51M-41.80%26.58M47.04%46.19M52.84%56.27M37.22%30.91M-22.81%45.66M-26.54%31.41M-27.88%36.81M
Net profit -11.20%355.45M-1.06%272.77M-5.68%145.26M18.77%506.11M32.02%400.29M38.88%275.68M40.75%154.01M17.69%426.11M2.00%303.2M-5.17%198.5M
Net profit from continuing operation -11.20%355.45M-1.06%272.77M-5.68%145.26M18.77%506.11M32.02%400.29M38.88%275.68M40.75%154.01M17.69%426.11M2.00%303.2M-5.17%198.5M
Less:Minority Profit 36.63%11.37M25.35%7.36M40.64%3.38M-36.23%9.59M-14.68%8.32M42.75%5.87M163.02%2.41M11.24%15.05M-18.15%9.75M-55.45%4.11M
Net profit of parent company owners -12.22%344.08M-1.63%265.4M-6.41%141.88M20.79%496.51M33.58%391.97M38.80%269.81M39.72%151.6M17.94%411.06M2.84%293.44M-2.85%194.39M
Earning per share
Basic earning per share -13.79%0.5-2.50%0.39-8.70%0.2119.35%0.7428.89%0.5833.33%0.435.29%0.2310.71%0.62-2.17%0.45-6.25%0.3
Diluted earning per share -12.28%0.5-2.56%0.38-4.55%0.2118.03%0.7229.55%0.5730.00%0.3929.41%0.228.93%0.61-2.22%0.44-6.25%0.3
Other composite income 208.26%74.96M96.98%27.33M-89.42%815.33K113.41%1.74M209.72%24.32M243.00%13.87M152.81%7.71M73.13%-12.94M53.84%-22.16M74.22%-9.7M
Other composite income of parent company owners 215.13%75.22M106.79%27.6M-89.77%807.37K110.56%1.49M201.01%23.87M228.81%13.35M154.25%7.89M70.52%-14.13M50.72%-23.63M72.38%-10.36M
Other composite income of minority owners -158.71%-262.39K-152.07%-273.92K104.40%7.95K-79.36%244.75K-69.55%446.91K-20.32%526.05K-240.36%-180.97K577.34%1.19M2,326.25%1.47M709.34%660.24K
Total composite income 1.37%430.41M3.64%300.09M-9.67%146.08M22.91%507.84M51.09%424.61M53.36%289.55M70.55%161.72M31.62%413.17M12.76%281.03M9.97%188.8M
Total composite income of parent company owners 0.83%419.3M3.48%293.01M-10.54%142.69M25.46%498M54.12%415.84M53.86%283.15M69.75%159.49M32.03%396.94M13.66%269.81M13.20%184.03M
Total composite income of minority owners 26.67%11.11M10.76%7.09M52.43%3.39M-39.38%9.84M-21.85%8.77M34.03%6.4M158.25%2.23M22.26%16.23M-5.31%11.22M-47.68%4.77M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)------Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday+0.70%
Assisted Reproduction
Assisted Reproduction
Intraday+0.68%
Ali Concept
Ali Concept
Intraday+0.64%